EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations

Ziyan Feng, Fanrong Zhao, Ziyao Wang, Xinyi Tang, Yan Xie, Li Qiu

BMC Gastroenterology · 15.03.2024 · 24 (1)

DOI: 10.1186/s12876-024-03192-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Gastroenterology, online erschienen am 15.03.2024. Verfasst von Ziyan Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guoxue Lane, …. Hauptthemen laut MEDLINE: Sarcopenia, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, National Clinical Research Center for Geriatrics, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed as a new term for diagnosing fatty liver disease, which is considered to be a multi-systemic disease with multiple extrahepatic manifestations, including sarcopenia. The link between sarcopenia and MAFLD remains uncertain, especially among young and middle-aged adults. Thus, we examined the relationship between MAFLD and sarcopenia in young and middle-aged individuals in this study.

Methods

A total of 2214 individuals with laboratory tests, dual-energy X-ray absorptiometry and ultrasound transient elastography from NHANES 2017–2018 were selected for this study. MAFLD was diagnosed as fatty liver disease with any one of the situations: overweight/obesity, diabetes mellitus, presence of metabolic dysregulation. Sarcopenia was defined by appendicular lean mass adjusted for body mass index (BMI). Multivariable logistic regression and restricted cubic spline (RCS) model were applied to explore the relationship between MAFLD and sarcopenia, and the mediation analyses were also conducted. Moreover, subgroup analyses stratified by BMI and lifestyles were done.

Results

The prevalence of MAFLD was 47.85%, and nearly 8.05% of participants had sarcopenia. The prevalence of sarcopenia was higher in participants with MAFLD (12.75%; 95% CI 10.18–15.31%) than in the non-MAFLD (3.73%; 95% CI 2.16–5.31%). MAFLD was significantly positively associated with sarcopenia after adjustments [OR = 2.87 (95% CI: 1.62–5.09)]. Moreover, significant positive associations were observed between liver fibrosis and sarcopenia prevalence in MAFLD patients (OR = 2.16; 95% CI 1.13–4.15). The RCS curve revealed that MAFLD was linearly associated with sarcopenia. The relationship between the MAFLD and sarcopenia were mediated by C-reactive protein (mediation proportion: 15.9%) and high-density lipoprotein cholesterol (mediation proportion: 18.9%). Subgroup analyses confirmed the association between MAFLD and sarcopenia differed in different lifestyle groups.

Conclusions

Both MAFLD prevalence and severity was significantly associated with sarcopenia. Thus, clinicians should advise comorbidity screening and lifestyle changes to young and middle-aged patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaNon-alcoholic Fatty Liver DiseaseAdultMiddle AgedHumansNutrition SurveysBody Mass IndexC-Reactive ProteinLiver Cirrhosis

Stichwörter der Autor:innen

Liver fibrosisMetabolic dysfunction-associated fatty liver diseaseObesitySarcopenia

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Department of Medical Ultrasound and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, China.
  • Department of gastroenterology, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, China.
  • Department of gastroenterology, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, China. xieyan@wchscu.cn.
  • Department of Medical Ultrasound and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, China. qiulihx@scu.edu.cn.

Förderung

  • 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project
  • National Clinical Research Center for Geriatrics
  • National Natural Science Foundation of China
  • health commission of Sichuan Provincial science and technology project
  • 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project

Zitieren

APA

Feng, Z., Zhao, F., Wang, Z., Tang, X., Xie, Y., & Qiu, L. (2024). The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations. BMC Gastroenterology, 24(1). https://doi.org/10.1186/s12876-024-03192-0

Vancouver

Feng Z, Zhao F, Wang Z, Tang X, Xie Y, Qiu L. The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations. BMC Gastroenterology. 2024;24(1). doi:10.1186/s12876-024-03192-0

BibTeX
@article{Feng2024,
  author = {Feng, Ziyan and Zhao, Fanrong and Wang, Ziyao and Tang, Xinyi and Xie, Yan and Qiu, Li},
  title = {The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations},
  journal = {BMC Gastroenterology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12876-024-03192-0}
}
Kostenlos starten →